Cencora | COR - Umsatzerlöse

Aktienkurs
311.43
Täglich Wechseln
-0.56 -0.18%
Monatlich
0.48%
Jährlich
6.41%
Q2 Prognose
301.59




Der Umsatz Veränderung Datum
Ambu A/S DKK 1.56B 90M 2025-12
Amplifon EUR 652M 88.7M 2025-12
Apollo Hospitals Enterprise Ltd INR 64.77B 1.73B 2025-12
Avanos Medical USD 180.9M 3.1M 2025-12
Brookdale Senior Living USD 754.09M 59.07M 2025-12
Cencora USD 85.93B 32.02M 2025-12
Coloplast 7.04B 83M 2025-12
Convatec Group USD 1.26B 80M 2025-12
Diasorin EUR 295M 15M 2025-12
Encompass Health USD 1.54B 60M 2025-12
Enovis USD 575.7M 26.8M 2025-12
GE HealthCare Technologies USD 5.7B 555M 2025-12
Gulf Medical Proj AED 213.77M 25.43M 2025-12
Hoya 244.7B 10.21B 2025-12
Med Life RON 787.96M 8.36M 2025-09
Oriola-kd EUR 502M 38.7M 2025-12
Pediatrix Medical Group USD 493.77M 896K 2025-12
Rede D'or Sao Luiz BRL 14.38B 220M 2025-12
Siemens Healthineers EUR 5.4B 920M 2025-12
Solventum Corp USD 1.99B 110M 2025-12
Sonova Holding CHF 1.82B 216.8M 2025-12
Supermax Corporation Bhd MYR 187.44M 18.13M 2025-12
Veradigm USD 142.52M 9.38M 2022-12
Zimmer Biomet Holdings USD 2.09B 150M 2026-03